Bcl-2 is a proto-oncogene which is involved in prolonging cell survival by inhibiting programmed cell death. Bax and bcl-x are members of the bcl-2 family; when overexpressed, they can counteract the ability of bcl-2 to inhibit apoptosis. This suggests a model in which the ratios of bcl-2 to bax and
Expression of Bcl-2 protein in human primary breast carcinomas and its correlation with multifocality, histopathological types and prognosis
โ Scribed by C.S Papadimitriou; J.S Costopoulos; B.P Christoforidou; A.J Kotsianti; G.S Karkavelas; P.M Hytiroglou; D.J Koufogiannis; H.E Nenopoulou
- Book ID
- 117663864
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 749 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: Recent studies on the role of bcl-2 in malignant tumors have suggested its prognostic significance. the goals of the current study were to determine any correlation between bcl-2 expression in esophageal squamous cell carcinoma and histopathology, lymph node metastasis, and clinical
## Abstract __MDR1__ is upregulated in many tumors. We have previously detected activation of the __MDR1__ upstream promoter in metastatic breast cancer cells. __MDR1__ overlaps with an uncharacterized gene transcribed from the opposite strand, coding for Rap2 interacting protein 9 (__RPIP9__). Rap